{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:52:45Z","timestamp":1791215565110,"version":"4.1.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1093\/brain\/aws280","type":"journal-article","created":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T06:02:08Z","timestamp":1360216928000},"page":"e231-e231","source":"Crossref","is-referenced-by-count":71,"title":["Idebenone treatment in patients with OPA1-mutant dominant optic atrophy"],"prefix":"10.1093","volume":"136","author":[{"given":"Piero","family":"Barboni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucia","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"La Morgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Carbonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Savini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"De Negri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Simonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Sadun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Caporali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Maresca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Baruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Zeviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Carelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,2,6]]},"reference":[{"key":"key\n\t\t\t\t20170405100152_aws280-B1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/79944","article-title":"OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to choromosome 3q28","volume":"26","author":"Alexander","year":"2000","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170405100152_aws280-B2","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2009.12.042","article-title":"OPA1 mutations associated with dominant optic atrophy influence optic nerve head size","volume":"117","author":"Barboni","year":"2010","journal-title":"Ophthalmology"},{"key":"key\n\t\t\t\t20170405100152_aws280-B3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbabio.2009.02.024","article-title":"Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders","volume":"1787","author":"Carelli","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20170405100152_aws280-B4","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1093\/brain\/awr180","article-title":"Idebenone treatment in Leber\u2019s hereditary optic neuropathy","volume":"134","author":"Carelli","year":"2011","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170405100152_aws280-B5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.preteyeres.2003.10.003","article-title":"Mitochondrial dysfunction as a cause of optic neuropathies","volume":"23","author":"Carelli","year":"2004","journal-title":"Prog Ret Eye Res"},{"key":"key\n\t\t\t\t20170405100152_aws280-B6","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/bjo.2007.134726","article-title":"The natural history of OPA1-related autosomal dominant optic atrophy","volume":"92","author":"Cohn","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"key\n\t\t\t\t20170405100152_aws280-B7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.21376","article-title":"Reversible optic neuropathy with OPA1 exon 5b mutation","volume":"63","author":"Cornille","year":"2008","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170405100152_aws280-B8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/79936","article-title":"Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy","volume":"26","author":"Delettre","year":"2000","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170405100152_aws280-B9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1096-7192(02)00145-2","article-title":"Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits","volume":"77","author":"Geromel","year":"2002","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405100152_aws280-B10","doi-asserted-by":"crossref","first-page":"e17963","DOI":"10.1371\/journal.pone.0017963","article-title":"NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels","volume":"6","author":"Haefeli","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170405100152_aws280-B11","first-page":"1","article-title":"Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families","volume":"37","author":"Kjer","year":"1959","journal-title":"Acta Ophthalmol Scand"},{"key":"key\n\t\t\t\t20170405100152_aws280-B12","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","article-title":"A randomized placebo-controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy","volume":"134","author":"Klopstock","year":"2011","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170405100152_aws280-B13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.semcdb.2009.12.012","article-title":"OPA1 (dys)functions","volume":"21","author":"Landes","year":"2010","journal-title":"Semin Cell Dev Biol"},{"key":"key\n\t\t\t\t20170405100152_aws280-B14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/bjo.2010.196782","article-title":"The influence of axial length on retinal nerve fiber layer thickness and optic disc size measurements by spectral-domain OCT","volume":"96","author":"Savini","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"key\n\t\t\t\t20170405100152_aws280-B15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/IJG.0b013e3181bdb55d","article-title":"Retinal nerve fiber layer thickness measurement by Fourier-domain optical coherence tomography: a comparison between Cirrus HD-OCT and RTVue in healthy eyes","volume":"19","author":"Savini","year":"2010","journal-title":"J Glaucoma"},{"key":"key\n\t\t\t\t20170405100152_aws280-B16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jmg.35.10.793","article-title":"Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy","volume":"35","author":"Votruba","year":"1998","journal-title":"J Med Genet"},{"key":"key\n\t\t\t\t20170405100152_aws280-B17","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1371\/journal.pgen.0040006","article-title":"The molecular mechanisms of OPA1-mediated optic atrophy in Drosophila model and prospects for antioxidant treatment","volume":"4","author":"Yarosh","year":"2008","journal-title":"PLoS Genet"},{"key":"key\n\t\t\t\t20170405100152_aws280-B18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","article-title":"Mitochondrial optic neuropathies -disease mechanisms and therapeutic strategies","volume":"30","author":"Yu-Wai-Man","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"key\n\t\t\t\t20170405100152_aws280-B19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awq007","article-title":"Multi-system neurological disease is common in patients with OPA1 mutations","volume":"133","author":"Yu-Wai-Man","year":"2010","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170405100152_aws280-B20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/brain\/awm335","article-title":"OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion","volume":"131","author":"Zanna","year":"2008","journal-title":"Brain"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/136\/2\/e231\/11137184\/aws280.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T20:11:57Z","timestamp":1503432717000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/aws280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,6]]},"published-print":{"date-parts":[[2013,2]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/aws280","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}